Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.23 - $160.0 $652,951 - $454 Million
2,838,918 Added 71.68%
6,799,636 $1.16 Million
Q2 2022

Aug 12, 2022

SELL
$0.23 - $0.46 $2.59 Million - $5.18 Million
-11,259,933 Reduced 73.98%
3,960,718 $1.05 Million
Q1 2022

May 12, 2022

SELL
$0.3 - $0.61 $76,809 - $156,179
-256,032 Reduced 1.65%
15,220,651 $6.52 Million
Q4 2021

Feb 10, 2022

SELL
$0.55 - $1.04 $22,185 - $41,950
-40,337 Reduced 0.26%
15,476,683 $8.5 Million
Q3 2021

Nov 09, 2021

SELL
$1.06 - $1.52 $38,496 - $55,201
-36,317 Reduced 0.23%
15,517,020 $16.4 Million
Q2 2021

Aug 11, 2021

BUY
$1.22 - $1.65 $19 Million - $25.7 Million
15,553,337 New
15,553,337 $23.5 Million

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.